337PED - PN-III-P2-2.1-PED-2019-3297
Platform is fully automated screening for small molecules with potential anti-inflammatory agent
PN 19.29.02.03
The molecular signature of response to anti-tumor in experimental models of metastasis
PN 18.21.02.01 the Profile of the molecular NK cells for the monitoring of therapy in cancer
PN 16.22.04.02 Nanosystems for the application at the request of the Candidate for adjunctive therapy in the treatment of cancer
PN 16.22.04.04 Immunotherapy focused on cancer, based on the profile of the molecular tumor
PN-II-RU-TE-2014-4-1811 Telocitele and stem cells therapy, promising to congestive heart failure
PN 09.33-04.17 Creating and suporting of a series of laboratory animals with the genetic makeup to be able to be used as the basis of the experimental
English (UK) 
Română